Indian Journal of Nuclear Medicine

CASE REPORT
Year
: 2011  |  Volume : 26  |  Issue : 4  |  Page : 188--191

Oncogenic osteomalacia diagnosed by blood pool scintigraphy


Shanmuga Sundaram Palaniswamy1, Padma Subramanyam1, Harish Kumar2 
1 Department of Nuclear Medicine and PET/CT, Amrita Institute of Medical Sciences and Research Center, Cochin, Kerala, India
2 Department of Endocrinology, Amrita Institute of Medical Sciences and Research Center, Cochin, Kerala, India

Correspondence Address:
Shanmuga Sundaram Palaniswamy
Consultant and Head, Department of Nuclear Medicine and PET/CT, Amrita Institute of Medical Sciences and Research Centre, Cochin - 680 2041, Kerala
India

Oncogenic osteomalacia is a rare metabolic bone disease characterized by phosphaturia and hypophosphatemia. Certain tumors secrete a phosphaturic factor, which results in this metabolic abnormality; this factor called as phosphatonin, is in fact a fibroblast growth factor 23 (FGF-23) involved closely in phosphate homeostasis and skeletogenesis. Complete excision of these tumors facilitates reversal of the problem. We have reported here the case of a patient who was crippled with this disease and on thorough investigation revealed an oncogenic osteomalacia with tumor focus in the right tibia. The tumor was identified as a mesenchymal tumor, i.e., hemangiopericytoma. Tumor excision alleviated patient symptoms with rapid symptomatic and biochemical improvement.


How to cite this article:
Palaniswamy SS, Subramanyam P, Kumar H. Oncogenic osteomalacia diagnosed by blood pool scintigraphy.Indian J Nucl Med 2011;26:188-191


How to cite this URL:
Palaniswamy SS, Subramanyam P, Kumar H. Oncogenic osteomalacia diagnosed by blood pool scintigraphy. Indian J Nucl Med [serial online] 2011 [cited 2020 Sep 24 ];26:188-191
Available from: http://www.ijnm.in/article.asp?issn=0972-3919;year=2011;volume=26;issue=4;spage=188;epage=191;aulast=Palaniswamy;type=0